ANDROGENIC DISEASE in MAN Georges Debled Research Foundation

ANDROGENIC DISEASE in MAN 2024

CONCLUSIONS SEMAL CONGRES March 2^nd 2024 BOGOTA

The key ageing disease (androgenic disease) is a common disease of ageing that must be treated in each individual after 40, and even before.

It is a universal disease that is involved in all diseases of ageing.

All anti-ageing methods must take into account the androgenic disease. Otherwise, they will fail.

The key ageing disease cannot be treated with testosterone pills, gel, subcutaneous injections or implants under the skin.

Disease of Ageing

This book explains the principles of the androgenic disease, and covers the management, details, and preventive treatment of ageing diseases.

It is based on elements of biochemistry, dynamic biochemistry, and clinical details.

It will help you understand and direct your prevention of age-related diseases.

CONCLUSIONS SEMAL CONGRES March 2^nd 2024 BOGOTA

THE KEY AGEING DISEASE

The key ageing disease is responsible for the transformation of the arterial musculature into fibrous cells because the muscle cells of the artery degenerate in the absence of anabolic molecules (mesterolone) from the age of forty and sometimes even earlier.

Thus the key ageing disease is the cause of arteriosclerosis which causes a decrease in the vascularization of all organs which are destroyed over time. These destructions characterize the diseases of ageing (Alzheimer's, Parkinson's, osteoarthritis, impotence, etc.).

The key ageing disease requires preventive treatment (mesterolone) from the age of forty and sometimes even earlier. At the beginning of degeneration, it is possible to see a curative effect. The treatment is inexpensive